Back to today’s briefing

Story perspectives

Harvard Study: Only 0.1% of Teens Use Gender Meds

1/7/2025

49 10

Summary

Story summary

A groundbreaking Harvard study uncovers that a mere 0.1% of U.S. teens accessed gender-affirming medications from 2018 to 2022, debunking myths of rampant over-prescription. Notably, no children under 12 received hormone treatments. As legislative pressures mount, experts urge for thoughtful conversations surrounding the healthcare of transgender youth.

1 of 1

Story summary

A groundbreaking Harvard study uncovers that a mere 0.1% of U.S. teens accessed gender-affirming medications from 2018 to 2022, debunking myths of rampant over-prescription. Notably, no children under 12 received hormone treatments. As legislative pressures mount, experts urge for thoughtful conversations surrounding the healthcare of transgender youth.